Neuroscience News and Research

RSS

New insights into understanding of neurological disorders

Increasingly sophisticated imaging tools and techniques are emerging that make it possible to probe the organization and activity of the brain at the cellular and molecular level, leading to a better understanding of the complex networks that link brain structure and function.

8 Jun 2011

Eating at wrong time of the day reduces fertility in fruit flies

Dieticians will tell you it isn't healthy to eat late at night: it's a recipe for weight gain. In fruit flies, at least, there's another consequence: reduced fertility.

8 Jun 2011

Dacogen Phase III study results on acute myeloid leukemia presented at ASCO 2011

Results from the DACO-016 trial of Dacogen (decitabine) in acute myeloid leukemia (AML) were presented today at the 2011 Annual Meeting of the American Society of Clinical Oncology (ASCO)

7 Jun 2011

Study finds consistent link between Parkinson's disease and melanoma

An analysis of several studies shows that people with Parkinson's disease have a significantly higher risk of melanoma, the most dangerous type of skin cancer and the leading cause of death from skin diseases.

7 Jun 2011

AstraZeneca receives AmeriCares' Power of Partnership Award for global health programs

AmeriCares has awarded its annual Power of Partnership Award to AstraZeneca for its outstanding commitment to increasing access to health care for people in need both here at home and throughout the developing world.

7 Jun 2011

Light exposure can enhance brain's visual circuits

Any parent knows that newborns still have a lot of neurological work to do to attain fully acute vision. In a wide variety of nascent animals, genes provide them with only a rough wiring plan and then leave it to the developing nervous system to do its own finish work.

6 Jun 2011

New UH Seidman Cancer Center center to offer latest treatments and technology

University Hospitals (UH) Seidman Cancer Center, Northeast Ohio's first and only freestanding cancer hospital, opens to patients on June 6. The ten-story, 150-bed cancer hospital will house the latest cancer-fighting treatments and technology – all in a patient-centered, healing-focused environment.

6 Jun 2011

Researchers discover a peptide that short circuits chronic pain pathway

Researchers at the Indiana University School of Medicine have discovered a peptide that short circuits a pathway for chronic pain. Unlike current treatments this peptide does not exhibit deleterious side effects such as reduced motor coordination, memory loss, or depression, according to an article in Nature Medicine posted online June 5, 2011.

6 Jun 2011

NYU Langone Medical Center achieves historic and unprecedented philanthropic milestone

NYU Langone Medical Center announced that it has reached a historic and unprecedented philanthropic milestone, raising $1 billion in less than four years.

6 Jun 2011

Results from HSPPC-96 Phase 2 study against recurrent gliobastoma presented at ASCO 2011

In data presented at The American Society of Clinical Oncology (ASCO) Annual Meeting, cancer researchers found that the brain tumor vaccine HSPPC-96 for treating recurrent gliobastoma (GBM) has a favorable safety profile and extends survival by two to three times more than the current median survival rate.

4 Jun 2011

Genentech, Astellas announce results of Tarceva Phase III study against advanced NSCLC

Genentech, a member of the Roche Group and Astellas Pharma US, Inc., today announced results of EURTAC, the first Phase III study with Tarceva in Western patients with a genetically distinct type of advanced non-small cell lung cancer (NSCLC).

4 Jun 2011

Patch-clamp recording reveals subtle differences between two neurotransmitter-gated ion channels

Using a high-resolution single-molecule study technique, University of Illinois researchers have seen the very subtle differences between two branches of an important family of neurotransmitter-gated ion channels.

3 Jun 2011

Teva completes patient enrollment in COPAXONE Phase III trial for treatment of multiple sclerosis

Teva Pharmaceutical Industries Ltd. today announced completion of patient enrollment for the GALA (Glatiramer Acetate Low-frequency Administration) trial.

3 Jun 2011

Scientists uncover new therapeutic target that could prevent stress-related cell death

Scientists from the Florida campus of The Scripps Research Institute have uncovered a potentially important new therapeutic target that could prevent stress-related cell death, a characteristic of neurodegenerative diseases such as Parkinson's, as well as heart attack and stroke.

3 Jun 2011

Scientists discover new compound that inhibits bitterness

Although bitterness can sometimes be desirable - such as in the taste of coffee or chocolate - more often bitter taste causes rejection that can interfere with food selection, nutrition and therapeutic compliance. This is especially true for children. Now, scientists from the Monell Center and Integral Molecular describe the discovery of a compound that inhibits bitterness by acting directly on a subset of bitter taste receptors.

3 Jun 2011

'Provision of choice' strategy helps improve vegetable consumption in children

A gesture as simple as allowing children to freely choose the vegetables they want to eat helps to increase the consumption of these foods in children, as University of Granada has found.

3 Jun 2011

Scientists locate brain region responsible for scene-facilitation effect

Scientists at the University of Southern California have pinned down the region of the brain responsible for a key survival trait: our ability to comprehend a scene-even one never previously encountered-in a fraction of a second.

2 Jun 2011

Preliminary results from Eisai's lenvatinib Phase II trial in thyroid cancer to be presented at ASCO 2011

Preliminary results of a Phase II single-arm study to be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting showed that Eisai's lenvatinib demonstrated an Objective Response Rate of 59% (34/58, 95% CI: 45-71), based on an updated investigator assessment, in patients with advanced radioiodine (RAI)-refractory differentiated thyroid cancer.

1 Jun 2011

Suberoylanilide hydroxamic acid holds promise against familial frontotemporal dementia

A drug already approved for people with cancer shows early potential as a therapy for a common form of dementia, UT Southwestern Medical Center researchers report.

1 Jun 2011

Heptares, AstraZeneca partner to discover and develop new GPCR drug targets

AstraZeneca and Heptares Therapeutics today announced they have entered a four-year collaboration focused on the potential discovery and development of new medicines targeting G-protein coupled receptors.

31 May 2011

Neuroscience News and Research

New insights into understanding of neurological disorders

Eating at wrong time of the day reduces fertility in fruit flies

Dacogen Phase III study results on acute myeloid leukemia presented at ASCO 2011

Study finds consistent link between Parkinson's disease and melanoma

AstraZeneca receives AmeriCares' Power of Partnership Award for global health programs

Light exposure can enhance brain's visual circuits

New UH Seidman Cancer Center center to offer latest treatments and technology

Researchers discover a peptide that short circuits chronic pain pathway

NYU Langone Medical Center achieves historic and unprecedented philanthropic milestone

Results from HSPPC-96 Phase 2 study against recurrent gliobastoma presented at ASCO 2011

Genentech, Astellas announce results of Tarceva Phase III study against advanced NSCLC

Patch-clamp recording reveals subtle differences between two neurotransmitter-gated ion channels

Teva completes patient enrollment in COPAXONE Phase III trial for treatment of multiple sclerosis

Scientists uncover new therapeutic target that could prevent stress-related cell death

Scientists discover new compound that inhibits bitterness

'Provision of choice' strategy helps improve vegetable consumption in children

Scientists locate brain region responsible for scene-facilitation effect

Preliminary results from Eisai's lenvatinib Phase II trial in thyroid cancer to be presented at ASCO 2011

Suberoylanilide hydroxamic acid holds promise against familial frontotemporal dementia

Heptares, AstraZeneca partner to discover and develop new GPCR drug targets

Neuroscience - Second Edition eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News